Patients with BRAF V600E-mutant metastatic colorectal cancer experienced poor clinical outcomes with systemic therapy, ...

Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

Discover recent advancements in near-infrared fluorescence imaging that have revolutionised lymph node tracing in cancers ...

The day was marked by the footprints of millions of devotees at the Maha Kumbh ground along the banks of the Ganga to seek ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, toda ...

High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of ...

The company announced interim data showing strong systemic responses in its safety and efficacy study combining Alpha DaRT treatment with ...

BRAF V600E-mutant metastatic colorectal cancer (CRC) was associated with poor clinical outcomes in patients receiving ...

Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

Bladder cancer is one of the most common malignant tumors in urinary system, and the treatment faces huge challenges.

Researchers have introduced an innovative surgical technique for treating bladder cancer that could revolutionize the field of urological oncology.

School of Life and Health Sciences, Hainan Province Key Laboratory of One Health, Collaborative Innovation Center of One Health, Hainan University, Haikou, Hainan 570228, China State Key Laboratory of ...